ARTG Entry
TERLIPRESSIN
ARTG entry for TERLIPRESSIN (terlipressin), ARTG 394190 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Southern XP IP
- Active ingredient: terlipressin
- Therapeutic area: Hepatology
I appreciate the request, but
I'm unable to write a comprehensive Brand Dossier for TERLIPRESSIN based on the provided source document.
The single source document contains only ARTG registration details (product codes, strengths, and registration dates). To create a Brand Dossier according to your specifications, I would need source documents that cover: — Clinical information (approved indications, dosing regimens) — Safety data (key warnings, contraindications) — PBS listing details (if applicable) — Regulatory history beyond ARTG registration dates (PBAC outcomes, AusPAR information)
From the available source, I can only reliably cite that TERLIPRESSIN is registered on the ARTG as a solution for injection containing 0.85 mg terlipressin acetate per 8.5 mL vial, with three variants first listed between 30 September and 1 October 2024 .
To produce a proper Brand Dossier, please provide source documents containing clinical, safety, and regulatory information for this medicine.